Why is Crizotinib 250 mg of crizotinib used?
Crizotinib, marketable under the brand name Crizotinib 250 mg, is a tyrosine kinase inhibitor (TKI) used in the treatment of certain types of cancer. This medication is primarily indicated for the management of non-small cell lung cancer (NSCLC) with specific genetic mutations, particularly those involving the anaplastic lymphoma kinase (ALK) gene rearrangement. Non-Small Cell Lung […]
